# Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke

> **NCT07690020** · NA · NOT_YET_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 216 (estimated)

## Conditions studied

- Ischemic Stroke, Acute

## Interventions

- **DRUG:** Getong Tongluo Capsule
- **OTHER:** Matched Starch Placebo Capsule
- **DRUG:** Standard Routine Therapy for Ischemic Stroke

## Key facts

- **NCT ID:** NCT07690020
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-07-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690020, "Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07690020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*